Article Versions Notes

Armocida D, Pesce A, Palmieri M, Cofano F, Palmieri G, Cassoni P, Busceti CL, Biagioni F, Garbossa D, Fornai F, et al. EGFR-Driven Mutation in Non-Small-Cell Lung Cancer (NSCLC) Influences the Features and Outcome of Brain Metastases. Journal of Clinical Medicine. 2023; 12(10):3372. https://doi.org/10.3390/jcm12103372

Armocida, Daniele, Alessandro Pesce, Mauro Palmieri, Fabio Cofano, Giuseppe Palmieri, Paola Cassoni, Carla Letizia Busceti, Francesca Biagioni, Diego Garbossa, Francesco Fornai, and et al. 2023. "EGFR-Driven Mutation in Non-Small-Cell Lung Cancer (NSCLC) Influences the Features and Outcome of Brain Metastases" Journal of Clinical Medicine 12, no. 10: 3372. https://doi.org/10.3390/jcm12103372

Armocida, D., Pesce, A., Palmieri, M., Cofano, F., Palmieri, G., Cassoni, P., Busceti, C. L., Biagioni, F., Garbossa, D., Fornai, F., Santoro, A., & Frati, A. (2023). EGFR-Driven Mutation in Non-Small-Cell Lung Cancer (NSCLC) Influences the Features and Outcome of Brain Metastases. Journal of Clinical Medicine, 12(10), 3372. https://doi.org/10.3390/jcm12103372